A well thought out clinical strategy is critical for a clinical study, our experts of clinical study talk about the following items in this webinar
- Impacts of correct study design (using some practical examples)
- Choice of expertise in protocol and study optimization
- Feasibility methodology in the choice of centers
- Choosing the right countries to give your study the best chance of success
Access the full webinar replay now
Fill in the form to download the content
Sample of the webinar
Featured Speakers
Dr. Nicola Wall, ACRP
Founder & CEO at Afortiori
Dr. Wall She has an exceptional background within the pharmaceutical, medical technology and healthcare sectors with over 20 years of diverse experience. She has hands-on experience in addressing the need for improved clinical trial design, planning and management to promote efficient and cost effective clinical trials. She has managed global clinical trials in Oncology and Neurology with responsibility for 29 countries across the entire clinical trial process.
Dr. Othar Zourabichvili
Founder & CEO at Quanta Medical
Medicine doctor, specialist of liver & GI tract diseases, Dr. Zourabichvili was 1st attaché as clinical consultant at AP-HP. Over the past 30 years has designed and conducted hundreds clinical trials in Europe for the pharmaceutical and medical device industries. Participated in the design and conduct of health risk assessment studies for international industrial groups. He is currently senior adviser for human health studies.
Dr. Anne Thorez
Senior Director, Patient Engagement at VCLS
Biologist by education, Dr. Thorez has worked in the pharmaceutical industry world for more than 25 years, in large companies as well as in start-up and small biotch companies, mostly in rare diseases, as a role of marketing and patient engagement. Over the years, Anne has developed strong relationships with different patient organizations, establishing patient’s voice empowerment in many projects , from support to trials enrolment and retention in order to develop educational material as well as to better understand patient’s journey and the burden of disease.
